Publications

  1. Wieruszewski PM, Sims CR, Daly RC, Taner T, Wittwer ED. Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology. J Cardiothorac Vasc Anesth 2019 Aug; 33 (8):2366-2367 Epub 2019 Mar 28
    View PubMed
  2. Abrol N, Jadlowiec CC, Taner T. Revisiting the liver's role in transplant alloimmunity. World J Gastroenterol. 2019 Jul 7; 25 (25):3123-3135
    View PubMed
  3. Iyer VN, Saberi B, Heimbach JK, Larson JJ, Raghavaiah S, Ditah I, Swanson K, Kamath PS, Watt KD, Taner T, Krowka MJ, Leise MD. Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States. Transplantation. 2019 Jul; 103 (7):1418-1424
    View PubMed
  4. Heimbach JK, Taner T. If You Can Look Into the Seeds of Time, and Say Which Grain Will Grow and Which Will Not. Hepatology. 2019 May 23 [Epub ahead of print]
    View PubMed
  5. Hofer RE, Vogt MNP, Taner T, Findlay JY. Influence of intraoperative transesophageal echocardiography monitoring on outcomes in liver transplantation. Pre-submission. 2019.
  6. Moreno M, Sanchez W, Taner T. Liver transplantation: When to say yes or no? Based on a case report Transplantation Reports. 2019; 4.
  7. Martins PN, Selzner M, Dayangac M, Ling Q, Ng KT, Huang KT, Taner T, Mas VR, Ekser B. What Is Hot and New in Basic Science in Liver Transplantation in 2018? Report of the Basic Science Committee of the International Liver Transplantation Society. Transplantation. 2019 Apr; 103 (4):654-659
    View PubMed
  8. Jadlowiec CC, Morgan PE, Nehra AK, Hathcock MA, Kremers WK, Heimbach JK, Wiesner RH, Taner T. Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection. Liver Transpl. 2019 Mar; 25 (3):425-435
    View PubMed
  9. Taner T, Heimbach JK. We (now) know what we are, but not what we may be. Transplantation. 2019 Feb 21 [Epub ahead of print]
    View PubMed
  10. Abrol N, Dean PG, Prieto M, Stegall MD, Taner T. Routine Stenting of Extravesical Ureteroneocystostomy in Kidney Transplantation: A Systematic Review and Meta-analysis. Transplant Proc. 2018 Dec; 50 (10):3397-3404 Epub 2018 June 30
    View PubMed
  11. Taner T. Current opinions in organ allocation American Journal of Transplantation. 2018; 18(11):2625-2634.
  12. Zamora-Valdes D, Watt KD, Kellogg TA, Poterucha JJ, Di Cecco SR, Francisco-Ziller NM, Taner T, Rosen CB, Heimbach JK. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy. Hepatology. 2018 Aug; 68 (2):485-495 Epub 2018 May 14
    View PubMed
  13. Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. Am J Transplant. 2018 Jul; 18 (7):1604-1614 Epub 2018 May 22
    View PubMed
  14. Taner T, Gustafson MP, Hansen MJ, Park WD, Bornschlegl S, Dietz AB, Stegall MD. Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year. Kidney Int. 2018 Jun; 93 (6):1465-1474 Epub 2018 Apr 12
    View PubMed
  15. Wong KL, Taner T, Smith BH, Kushwaha SS, Edwards BS, Gandhi MJ, Kremers WK, Daly RC, Pereira NL. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation. Circulation 2017 Oct 3; 136 (14):1350-1352
    View PubMed
  16. Taner T. Liver transplantation: Rejection and tolerance. Liver Transpl. 2017 Oct; 23 (S1):S85-S88
    View PubMed
  17. Zamora-Valdes D, Taner T, Nagorney DM. Surgical Treatment of Hepatocellular Carcinoma. Cancer Control. 2017 Jul-Sep; 24 (3):1073274817729258
    View PubMed
  18. Taner T, Park WD, Stegall MD. Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation. Kidney Int. 2017 May; 91 (5):1193-1202 Epub 2017 Feb 21
    View PubMed
  19. Taner T. The highly sensitized, high MELD, simultaneous liver-kidney or status 1A heart-liver transplant candidate. Clin Liver Dis (Hoboken). 2017 Jan; 9 (1):18-20 Epub 2017 Feb 03
    View PubMed
  20. Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, Stegall MD, Heimbach JK, Taner T. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation. Am J Transplant. 2016 Dec; 16 (12):3522-3531 Epub 2016 June 24
    View PubMed
  21. Zamora-Valdes D, Rosen CB, Heimbach JK, Taner T. Late Choledochojejunostomy Dysfunction After Liver Transplantation for Primary Sclerosing Cholangitis. Am J Transplant 2016 Dec; 16 (12):3574-3576
    View PubMed
  22. Moreno Gonzales M, Myhre L, Taner T. Sublingual Tacrolimus in Liver Transplantation: A Valid Option? Transplant Proc. 2016 Jul-Aug; 48 (6):2102-6
    View PubMed
  23. Jadlowiec CC, Taner T. Liver transplantation: Current status and challenges. World J Gastroenterol. 2016 May 14; 22 (18):4438-45
    View PubMed
  24. Taner T, Heimbach JK, Rosen CB, Nyberg SL, Park WD, Stegall MD. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney Int. 2016 Apr; 89: (4)909-17.
    View PubMed
  25. Gonzales MM, Valdes DZ, Helmick R, Taner T, Vasdev G. Is There a Role for Desmopressin in Liver Transplantation? A Case Report. Transplant Proc. 2015 Nov; 47 (9):2782-5
    View PubMed
  26. Taner T, Iqbal CW, Textor SC, Stegall MD, Ishitani MB. Compensatory hypertrophy of the remaining kidney in medically complex living kidney donors over the long term. Transplantation. 2015 Mar; 99(3):555-9.
    View PubMed
  27. Jadlowiec CC, Taner T. Advancing Liver Transplantation. Clin Transpl. 2015; 31:181-191.
    View PubMed
  28. Chedid MF, Moreno Gonzales M, Raghavaiah S, Chauhan A, Taner T, Nedredal GI, Park WD, Stegall MD. Renal retransplantation after kidney and pancreas transplantation using the renal vessels of the failed allograft: pitfalls and pearls. Clin Transplant. 2014 Jun; 28(6):669-74. Epub 2014 Apr 18.
    View PubMed
  29. Taner T, Stegall MD, Heimbach JK. Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl. 2014 May; 20(5):514-27. Epub 2014 Feb 25.
    View PubMed
  30. Merchea A, Abdelsattar ZM, Taner T, Dean PG, Colibaseanu DT, Larson DW, Dozois EJ. Outcomes of colorectal cancer arising in solid organ transplant recipients. J Gastrointest Surg. 2014 Mar; 18 (3):599-604 Epub 2013 Nov 20
    View PubMed
  31. Stegall MD, Moore N, Taner T, Li H, Dean PG. Down-regulating humoral immune responses: implications for organ transplantation. Transplantation. 2014 Feb 15; 97(3):247-57.
    View PubMed
  32. Taner T, Nagorney DM, Tefferi A, Habermann TM, Harmsen WS, Slettedahl SW, Donohue JH. Splenectomy for massive splenomegaly: long-term results and risks for mortality. Ann Surg. 2013 Dec; 258(6):1034-9.
    View PubMed
  33. Taner T, Atwell TD, Zhang L, Oberg TN, Harmsen WS, Slettedahl SW, Kendrick ML, Nagorney DM, Que FG. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection. HPB (Oxford). 2013 Mar; 15 (3):190-5 Epub 2012 July 26
    View PubMed
  34. Taner T, Gandhi MJ, Sanderson SO, Poterucha CR, De Goey SR, Stegall MD, Heimbach JK. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant. 2012 Jun; 12(6):1504-10. Epub 2012 Mar 15.
    View PubMed
  35. Ehman EC, Kaplan KJ, Kim BD, Taner T. Multifocal inflammatory fibroid polyps of the ileum. Am Surg 2010 Dec; 76 (12):E227-9
    View PubMed
  36. Bogert JN, Taner T, Nagorney DM. Education and imaging. Hepatobiliary and pancreatic: Mucinous cystadenoma of the biliary tree. J Gastroenterol Hepatol. 2010 Jul; 25: (7)1332.
    View PubMed
  37. Taner T, Cima RR, Larson DW, Dozois EJ, Pemberton JH, Wolff BG. Surgical treatment of complex enterocutaneous fistulas in IBD patients using human acellular dermal matrix. Inflamm Bowel Dis. 2009 Aug; 15 (8):1208-12
    View PubMed
  38. Taner T, Cima RR, Larson DW, Dozois EJ, Pemberton JH, Wolff BG. The use of human acellular dermal matrix for parastomal hernia repair in patients with inflammatory bowel disease: a novel technique to repair fascial defects. Dis Colon Rectum. 2009 Feb; 52: (2)349-54.
    View PubMed
  39. Fischer R, Turnquist HR, Taner T, Thomson AW. Use of rapamycin in the induction of tolerogenic dendritic cells. Handb Exp Pharmacol. 2009; (188)(188)215-32.
    View PubMed
  40. Hackstein H, Steinschulte C, Fiedel S, Eisele A, Rathke V, Stadlbauer T, Taner T, Thomson AW, Tillmanns H, Bein G, Holschermann H. Sanglifehrin a blocks key dendritic cell functions in vivo and promotes long-term allograft survival together with low-dose CsA. Am J Transplant. 2007 Apr; 7(4):789-98.
    View PubMed
  41. Wang Z, Taner T, Morelli AE, Thomson AW. Hosts lacking fms-like tyrosine kinase 3 ligand exhibit marked reductions in transplant vascular sclerosis. Transplantation. 2005 Apr 27; 79(8):869-75.
    View PubMed
  42. Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant. 2005 Feb; 5(2):228-36.
    View PubMed
  43. Taner T, Thomson AW. Fashioning regulatory dendritic cells: what is currently in vogue? Curr Opin Mol Ther. 2004 Feb; 6(1):78-82.
    View PubMed
  44. Steinschulte C, Taner T, Thomson AW, Bein G, Hackstein H. Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells. J Immunol. 2003 Jul 15; 171(2):542-6.
    View PubMed
  45. Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, Gessner A, Thomson AW. Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood. 2003 Jun 1; 101(11):4457-63. Epub 2003 Jan 16.
    View PubMed
  46. Coates PT, Colvin BL, Kaneko K, Taner T, Thomson AW. Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity. Transplantation. 2003 May 15; 75(9 Suppl):32S-36S.
    View PubMed
  47. Hackstein H, Taner T, Logar AJ, Thomson AW. Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. Blood. 2002 Aug 1; 100(3):1084-7.
    View PubMed